volume 330 pages 109244

2-aminothiazoles in drug discovery: Privileged structures or toxicophores?

Žiga Jakopin 1, 2, 3
1
 
Faculty of Pharmacy
3
 
Aškerčeva 7, SI-1000 Ljubljana Slovenia
Publication typeJournal Article
Publication date2020-10-01
scimago Q1
wos Q1
SJR1.120
CiteScore8.6
Impact factor5.4
ISSN00092797, 18727786
General Medicine
Toxicology
Abstract
The 2-aminothiazole functionality has long been established as a privileged structural feature and therefore frequently exploited in the process of drug discovery and development. It has been introduced into numerous compounds due to its capacity for targeting a wide range of therapeutic target proteins. On the other hand, the aminothiazole group has also been classified as a toxicophore susceptible to metabolic activation and the ensuing reactive metabolite formation, hence caution is warranted when used in drug design. This review is divided into three parts entailing: (i) the general characteristics of the aminothiazole group, (ii) the advantages of the aminothiazole group in medicinal chemistry, and (iii) the impact of the integrated aminothiazole group on compound safety profile.
Found 
Found 

Top-30

Journals

1
2
3
4
Journal of Organic Chemistry
4 publications, 10.53%
ChemistrySelect
2 publications, 5.26%
Organic Letters
2 publications, 5.26%
Molecular Diversity
2 publications, 5.26%
Journal of Environmental Chemical Engineering
1 publication, 2.63%
New Journal of Chemistry
1 publication, 2.63%
Phosphorus, Sulfur and Silicon and the Related Elements
1 publication, 2.63%
Heterocycles
1 publication, 2.63%
European Journal of Organic Chemistry
1 publication, 2.63%
Drug Discovery Today
1 publication, 2.63%
Applied Organometallic Chemistry
1 publication, 2.63%
Bioorganic Chemistry
1 publication, 2.63%
Journal of Saudi Chemical Society
1 publication, 2.63%
Journal of Heterocyclic Chemistry
1 publication, 2.63%
Journal of Applied Polymer Science
1 publication, 2.63%
Journal of Thermal Analysis and Calorimetry
1 publication, 2.63%
Journal of Inorganic Biochemistry
1 publication, 2.63%
RSC Advances
1 publication, 2.63%
Mendeleev Communications
1 publication, 2.63%
International Journal of Molecular Sciences
1 publication, 2.63%
Chemistry of Natural Compounds
1 publication, 2.63%
Chemistry and Chemical Technology
1 publication, 2.63%
ChemPlusChem
1 publication, 2.63%
International Journal of Biological Macromolecules
1 publication, 2.63%
Tetrahedron
1 publication, 2.63%
Journal of Molecular Structure
1 publication, 2.63%
BMC Chemistry
1 publication, 2.63%
Journal of the Indian Chemical Society
1 publication, 2.63%
ACS Omega
1 publication, 2.63%
1
2
3
4

Publishers

2
4
6
8
10
12
Elsevier
11 publications, 28.95%
Wiley
7 publications, 18.42%
American Chemical Society (ACS)
7 publications, 18.42%
Springer Nature
5 publications, 13.16%
Royal Society of Chemistry (RSC)
2 publications, 5.26%
Taylor & Francis
1 publication, 2.63%
The Japan Institute of Heterocyclic Chemistry
1 publication, 2.63%
OOO Zhurnal "Mendeleevskie Soobshcheniya"
1 publication, 2.63%
MDPI
1 publication, 2.63%
Lviv Polytechnic National University
1 publication, 2.63%
Cold Spring Harbor Laboratory
1 publication, 2.63%
2
4
6
8
10
12
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
38
Share
Cite this
GOST |
Cite this
GOST Copy
Jakopin Ž. 2-aminothiazoles in drug discovery: Privileged structures or toxicophores? // Chemico-Biological Interactions. 2020. Vol. 330. p. 109244.
GOST all authors (up to 50) Copy
Jakopin Ž. 2-aminothiazoles in drug discovery: Privileged structures or toxicophores? // Chemico-Biological Interactions. 2020. Vol. 330. p. 109244.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1016/j.cbi.2020.109244
UR - https://doi.org/10.1016/j.cbi.2020.109244
TI - 2-aminothiazoles in drug discovery: Privileged structures or toxicophores?
T2 - Chemico-Biological Interactions
AU - Jakopin, Žiga
PY - 2020
DA - 2020/10/01
PB - Elsevier
SP - 109244
VL - 330
PMID - 32861748
SN - 0009-2797
SN - 1872-7786
ER -
BibTex
Cite this
BibTex (up to 50 authors) Copy
@article{2020_Jakopin,
author = {Žiga Jakopin},
title = {2-aminothiazoles in drug discovery: Privileged structures or toxicophores?},
journal = {Chemico-Biological Interactions},
year = {2020},
volume = {330},
publisher = {Elsevier},
month = {oct},
url = {https://doi.org/10.1016/j.cbi.2020.109244},
pages = {109244},
doi = {10.1016/j.cbi.2020.109244}
}